Global Prescription Dermatology Therapeutics Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
“Global Prescription Dermatology Therapeutics Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global prescription dermatology therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global prescription dermatology therapeutics market report has been segmented on the basis of product type, distribution channel, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the global market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the global prescription dermatology therapeutics market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Dermatology is the branch of medicines that deals with medicines and therapeutic solutions for skin, nails, hair and its related diseases. The skin related disease differs based on region and country and the therapeutic solutions related with dermatology also differs accordingly.
Increasing incidence and prevalence of infectious disorders related with skin, nails, and hair among individuals across the globe, is a key factor expected to drive growth of the global prescription dermatology therapeutics market during the forecast period. In addition, increasing awareness about available dermatology solutions among patient is another factor expected to boost growth of the target market in the near future.
Moreover, rising demand for homeopathy dermatology therapeutics, owing to their low cost and high effectivity and safety is expected to burgeon growth of the global prescription dermatology therapeutics market in the near future.
Increasing awareness about physical appearance among individuals across the globe and increased disposable income expected to boost demand for therapeutic solutions to treat skin related disease such as acne vulgaris, disseminated lupus, erythematosus, and Hansen disease across the globe. This in turn expected to proliferate growth of the target market during the forecast period.
Furthermore, increasing preferences for biologics in developing new dermatological treatment solutions with unique organic components by various pharmaceuticals industries is expected to support for business expansion of players in the global market.
However, increasing stringent healthcare regulations by healthcare authorities and rising concerns associated with drug safety and quality of prescription therapeutics among individuals across the globe are major factors expected to restrain growth of target market to a certain extent.
On the basis of product type, the psoriasis drugs segment is expected to dominate the global market, owing to increasing prevalence and incidence of severe plaque psoriasis across the globe. In addition, increasing research and development for effective treatment of psoriasis across the globe is another factor supporting growth of the global market.
On the basis of distribution channel, the hospital pharmacies segment is expected to dominate the global market, owing to increasing rate of patient admissions in hospitals and high availability of dermatology therapeutics in hospital pharmacies across the globe.
The market in North America is expected to dominate in the global prescription dermatology therapeutics market. This is primarily attributed to strong presence of leading dermatology therapeutic solutions manufacturers and high availability of variety of dermatology therapeutics in countries in the region. The market in Asia Pacific is expected to register highest CAGR over the forecast period, owing to increasing awareness about various dermatology therapeutics for skin disorders, increasing incidence of chronic dermatological disorders, and increasing development in health care infrastructure in countries in the region.
Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register significant revenue growth in the global prescription dermatology therapeutics market over the forecast period.
Global Prescription Dermatology Therapeutics Market Segmentation:
Segmentation by Product Type:
- Psoriasis Drugs
- Skin Cancer Drugs
- Acne and Rosacea Drugs
- Fungal Infection Drugs
- Dermatitis and Seborrhea Drugs
- Others (Hyperpigmentation/ Melisma Drugs, Hair Loss and Hair Removal Drugs, and Antiaging and Photo Damage Drugs)
Segmentation by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- AbbVie, Inc.
- Pfizer, Inc.
- Amgen, Inc.
- Janssen Biotech, Inc.
- Celgene Corporation
- Eli Lilly and Company
- Sun Pharmaceuticals Ltd.
- Aclaris Therapeutics, Inc.
- Aurobindo Pharma Ltd.
- Bausch Health Companies, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!